Tag: MDD

A combined mindfulness and behavioral activation intervention is shown to reduce depressive symptoms and serve as a preventative factor for major depressive disorder.

The 1 Boring Old Man blog discusses how MDD started as a “Descriptor, then became a Disorder, then became a Brain Disease, and now seems have...

Mindfulness-based cognitive therapy (MBCT) may be more effective at reducing the risk of depressive relapse compared to current standard treatments with antidepressant drugs. A...

Since the 1980s, antidepressant use has risen by at least four-hundred percent and obesity rates have climbed to include thirty percent of the population....

According to a study published in this month’s British Journal of Psychiatry, people diagnosed with depression in high-income countries are more likely to limit...

In 2014, then National Institute of Mental Health (NIMH) director, Thomas Insel, speculated that ketamine “might be the most important breakthrough in antidepressant treatment in decades.” A recent review of the research suggests that while ketamine may produce a rapid short-term improvement in depression, the effect is short-lived and the potential for addiction and dependence warrants considerable caution.

A new study on the depression symptoms of over three-thousand patients challenges the criteria used for diagnosing major depression with the latest Diagnostic and Statistical Manual (DSM-5). Current diagnostic systems are based on an assumption that the symptoms of depression point to a common underlying “illness," but research suggests that this framework may be outdated and oversimplified.

People diagnosed with severe depression show the same changes in brain scans when they respond to a placebo as they do when they take an actual antidepressant, according to a new study. Researchers also found that those whose symptoms were decreased by a placebo were more likely to report relief from antidepressant drugs.